全文获取类型
收费全文 | 215005篇 |
免费 | 19582篇 |
国内免费 | 11863篇 |
专业分类
耳鼻咽喉 | 1933篇 |
儿科学 | 2764篇 |
妇产科学 | 2413篇 |
基础医学 | 30078篇 |
口腔科学 | 3800篇 |
临床医学 | 25183篇 |
内科学 | 32296篇 |
皮肤病学 | 2759篇 |
神经病学 | 11145篇 |
特种医学 | 8324篇 |
外国民族医学 | 82篇 |
外科学 | 21726篇 |
综合类 | 32575篇 |
现状与发展 | 43篇 |
一般理论 | 33篇 |
预防医学 | 14432篇 |
眼科学 | 5383篇 |
药学 | 23490篇 |
166篇 | |
中国医学 | 10685篇 |
肿瘤学 | 17140篇 |
出版年
2024年 | 724篇 |
2023年 | 3097篇 |
2022年 | 7907篇 |
2021年 | 10391篇 |
2020年 | 7493篇 |
2019年 | 6809篇 |
2018年 | 7213篇 |
2017年 | 6549篇 |
2016年 | 6562篇 |
2015年 | 9468篇 |
2014年 | 11595篇 |
2013年 | 11446篇 |
2012年 | 16311篇 |
2011年 | 17194篇 |
2010年 | 11982篇 |
2009年 | 9637篇 |
2008年 | 11812篇 |
2007年 | 11767篇 |
2006年 | 10773篇 |
2005年 | 10008篇 |
2004年 | 7656篇 |
2003年 | 7451篇 |
2002年 | 6339篇 |
2001年 | 5177篇 |
2000年 | 4422篇 |
1999年 | 3943篇 |
1998年 | 2332篇 |
1997年 | 2419篇 |
1996年 | 1678篇 |
1995年 | 1687篇 |
1994年 | 1456篇 |
1993年 | 1005篇 |
1992年 | 1384篇 |
1991年 | 1243篇 |
1990年 | 1087篇 |
1989年 | 1024篇 |
1988年 | 879篇 |
1987年 | 816篇 |
1986年 | 751篇 |
1985年 | 575篇 |
1984年 | 480篇 |
1983年 | 389篇 |
1982年 | 320篇 |
1981年 | 271篇 |
1980年 | 240篇 |
1979年 | 273篇 |
1978年 | 229篇 |
1977年 | 257篇 |
1976年 | 225篇 |
1974年 | 203篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Feng Wang Dachuan Wang Bingyi Tan Jun Dong Rongjie Feng Zenong Yuan Naiguo Wang 《Medicine》2015,94(39)
The present study aimed at examining the curative effect of modified posterior operation on treatment of Kümmell''s disease.About 30 patients of Kümmell''s disease with complete image and clinical data treated during June 2004 to July 2013 were conducted with anterior and posterior approaches, respectively. Kyphotic Cobb angle, fractured vertebra wedge angle, and the anterior and posterior heights of fractured vertebra were all measured through x-ray before and after operation, and the pain visual analog scale (VAS) was determined for evaluating the effect of operations. The injury and restoration of neurological function were assessed using Frankel classification.Patients in group A were treated with anterior operation, whereas group B was posterior operation. Postoperatively, VAS score, kyphotic Cobb angle, anterior vertebra height, and pathologic vertebra wedge angle were all significantly improved in patients with Kümmell''s disease receiving modified posterior operation (group B). Similar results were also observed in patients with anterior operation. The improvement of VAS and correction rate of kyphotic Cobb angle indicated equivalent effects of posterior and anterior operations. Meanwhile, alleviated neurological function damage was observed in 2 groups. Relevant factor analysis illustrated that there was no significant correlation of the severity and improvement rate of pain symptoms with age, medical history, anterior and posterior vertebra heights, kyphotic Cobb angle, and pathological vertebra wedge angle.Compared with traditional anterior approach, modified posterior operation, adopting transpedicular vertebral body grafting combined with vertebral pedicle screw fixation, could produce equivalent effects on kyphosis correction, pain relief, and improvement of neurological function in patients with Kümmell''s disease. 相似文献
2.
3.
European Archives of Oto-Rhino-Laryngology - Several polymorphisms in a disintegrin and metalloproteinase 33 (ADAM33) have been implicated in susceptibility to allergic rhinitis (AR), but the... 相似文献
4.
Dan-Feng Xu Bing Wu Jin-Xin Wang Jian Yu Jian-Xin Xie 《World Journal of Clinical Cases》2021,9(5):1096-1102
BACKGROUNDGuillain-Barré syndrome (GBS) is a rare disorder that typically presents with ascending weakness, pain, paraesthesias, and numbness, which mimic the findings in lumbar spinal stenosis. Here, we report a case of severe lumbar spinal stenosis combined with GBS.CASE SUMMARYA 70-year-old man with a history of lumbar spinal stenosis presented to our emergency department with severe lower back pain and lower extremity numbness. Magnetic resonance imaging confirmed the diagnosis of severe lumbar spinal stenosis. However, his symptoms did not improve postoperatively and he developed dysphagia and upper extremity numbness. An electromyogram was performed. Based on his symptoms, physical examination, and electromyogram, he was diagnosed with GBS. After 5 d of intravenous immunoglobulin (0.4 g/kg/d for 5 d) therapy, he gained 4/5 of strength in his upper and lower extremities and denied paraesthesias. He had regained 5/5 of strength in his extremities when he was discharged and had no symptoms during follow-up.CONCLUSIONGBS should be considered in the differential diagnosis of spinal disorder, even though magnetic resonance imaging shows severe lumbar spinal stenosis. This case highlights the importance of a careful diagnosis when a patient has a history of a disease and comes to the hospital with the same or similar symptoms. 相似文献
5.
Hyo-Kon Kim Sung-Han Ha Gi-Jun Lee Sun-O Yu Jung-Rae Kim 《Clinics in Orthopedic Surgery》2015,7(3):414-417
Synovial chondromatosis is a rare lesion in the wrist, but some cases in the distal radioulnar joint have been reported and previous case reports emphasize joint calcifications, shown on preoperative plain radiographs. We report an extremely uncommon case of synovial chondromatosis in the pisotriquetral joint, in which radiographs and magnetic resonance imaging did not demonstrate apparent calcified bodies. In our case, for the accurate diagnosis and treatment, surgical exploration of the joint and synovectomy with removal of loose bodies was performed. 相似文献
6.
7.
8.
9.
Assessment of Myocardial Infarct Size by Three‐Dimensional and Two‐Dimensional Speckle Tracking Echocardiography: A Comparative Study to Single Photon Emission Computed Tomography 下载免费PDF全文
10.
Richard Kim Elaine Tan Emily Wang Amit Mahipal Dung-Tsa Chen Biwei Cao Fadzai Masawi Cindy Machado James Yu Dae Won Kim 《The oncologist》2020,25(12):e1893-e1899
Lessons Learned
- The combination of trametinib and sorafenib has an acceptable safety profile, albeit at doses lower than approved for monotherapy.
- Maximum tolerated dose is trametinib 1.5 mg daily and sorafenib 200 mg twice daily.
- The limited anticancer activity observed in this unselected patient population does not support further exploration of trametinib plus sorafenib in patients with hepatocellular carcinoma.